Lawrence E. Flaherty

8.3k citations
118 papers · 5.4k · 2 hit papers · h-index 38

Impact in

  • Oncology top 0.5%
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Immunology top 1%
    • Immunotherapy and Immune Responses

Papers in

    • Cutaneous Melanoma Detection and Management 19
    • CAR-T cell therapy research 17
    • Cancer Immunotherapy and Biomarkers 15
    • Melanoma and MAPK Pathways 25
    • Cancer therapeutics and mechanisms 7

Lawrence E. Flaherty

116 papers receiving 5.2k citations

Lawrence E. Flaherty's Hit Papers

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma 2004 · 602 citations
6020+8+17Years since publication200400600

Peers

Lawrence E. Flaherty
Comparison fields: 5 of 116
  • Oncology 2.9k
  • Immunology 1.5k
  • Cancer Research 476
  • Pulmonary and Respiratory Medicine 1.0k
  • Molecular Biology 2.1k
Replace Steinar Aamdal with:
Steinar Aamdal Norway
Michael Millward Australia
Elisabeth Paietta United States
Ana Arance Spain
Helen Gogas Greece
Sylvie Rottey Belgium
Victoria Atkinson Australia
Ahmad A. Tarhini United States
Jacob Schachter Israel
Wells A. Messersmith United States
Lawrence E. Flaherty relative to Steinar Aamdal Norway Steinar Aamdal's profile →
Citations per field
00.5×1.5×
Steinar Aamdal · 1×
Citations per year

Countries citing papers authored by Lawrence E. Flaherty

Since Specialization
Citations

This map shows the geographic impact of Lawrence E. Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence E. Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence E. Flaherty more than expected).

Fields of papers citing papers by Lawrence E. Flaherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence E. Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence E. Flaherty. The network helps show where Lawrence E. Flaherty may publish in the future.

Co-authors

The 25 scholars most cited alongside Lawrence E. Flaherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence E. Flaherty Line = papers co-authored together Lawrence E. Flaherty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190
Hit paper breakdown →
2000662
2
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
Hit paper breakdown →
2004602
3 2008228
4 2014203
5 1994171
6 2002162
7 2012160
8 2005159
9 2002139
10 1998137
11 1998135
12 2004135
13 2011116
14 2001115
15 2002113
16 199594
17 200285
18 201483
19 199583
20 200873

About Lawrence E. Flaherty

Lawrence E. Flaherty is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 118 papers that have together received 5.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (25 papers), Immunotherapy and Immune Responses (21 papers), Cutaneous Melanoma Detection and Management (19 papers), CAR-T cell therapy research (17 papers), Cancer Immunotherapy and Biomarkers (15 papers), Click Chemistry and Applications (8 papers), Cancer therapeutics and mechanisms (7 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Oncology (2.9k citations), Immunology (1.5k citations), Cancer Research (476 citations), Pulmonary and Respiratory Medicine (1.0k citations) and Molecular Biology (2.1k citations). Lawrence E. Flaherty has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Vernon K. Sondak, John M. Kirkwood, Bruce G. Redman, Jeffrey A. Sosman, Marc S. Ernstoff, Jon Richards, Michael B. Atkins, Joseph M. Unger, Ehab Atallah and Joseph G. Ibrahim. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Investigational New Drugs, Journal of Immunotherapy and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact